3-(4-Methoxy-3-(piperidin-1-ylsulfonyl)phenyl)propanoic acid

Catalog No.: 
ACXFLV547
CAS No.: 
1707581-93-8
Molecular Formula: 
C15H21NO5S
Molecular Weight: 
327.40
3-(4-Methoxy-3-(piperidin-1-ylsulfonyl)phenyl)propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$204.00InquiryInquiry
1g97%$599.00InquiryInquiry
5g97%$2935.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Methoxy-3-(piperidin-1-ylsulfonyl)phenyl)propanoic acid
IUPAC Name3-(4-methoxy-3-(piperidin-1-ylsulfonyl)phenyl)propanoic acid
MDL No.MFCD26381564
Molecular FormulaC15H21NO5S
Molecular Weight327.40
SMILESO=C(O)CCC1=CC=C(OC)C(S(=O)(N2CCCCC2)=O)=C1
InChI KeyKLENZCXJANPISE-UHFFFAOYSA-N
Synonym3-[4-Methoxy-3-(piperidine-1-sulfonyl)-phenyl]-propionic acid;Benzenepropanoic acid, 4-methoxy-3-(1-piperidinylsulfonyl)-
CAS No.1707581-93-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXFLV547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXFLV547 route product structure diagram
    ACXFLV5471707581-93-8
Inquiry

2. ACXFLV547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXFLV547 route product structure diagram
    ACXFLV5471707581-93-8
Inquiry

3. ACXFLV547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXFLV547 route product structure diagram
    ACXFLV5471707581-93-8
Inquiry

Comments (0)